Skandinaviska Enskilda Banken (SEB)
SRRA

Skandinaviska Enskilda Banken (SEB)’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,685
Closed -$753K – 1067
2022
Q2 		$753K Buy
+13,685
New +$718K 0.01% 750

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s SRRA Position: Q3 2022 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 13,685 shares — an estimated $753K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $753K in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 13,685 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $753K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Skandinaviska Enskilda Banken (SEB)'s Sierra Oncology, Inc. Common Stock position peaked at $753K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2022, filed 14 Nov 2022.